B+ Bausch + Lomb Corporation Stock: price and directors' dealings · Canada · SEDISource id SEDI:bausch-lomb-corporation CA · SEDI Mcap CA$8.4B 医疗保健 Track the Bausch + Lomb Corporation share price and the full insider trade history of the company, a publicly traded company based in Canada. Shares are quoted on the CA market, under the supervision of SEDI. Operating in the Health Care sector, Bausch + Lomb Corporation has published 49 insider filings. Market capitalisation: €8.4bn. The latest transaction was filed on 14 August 2026 (56 - Grant of rights). Among the most active insiders: Munsch, Frederick John. All data is accessible without an account.
Analyst consensus: bullish or bearish? Analysts rate Bausch + Lomb Corporation Buy (bullish), based on 1 analysts. Average price target: CA$25.09.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,391 of 29,063 companies
FCF yld -0.8%
Earn yld -4.2%
EV/EBITDA 25.9x
ROE -2.5%
Gross mgn 60%
Net mgn -7.1%
Debt/EBITDA 9.7x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 August 2026
All Executives49 Thresholds0 Prospectus0 Other0
Declarations 49 total
● 4 - Director of Issuer · Executives · 12 Aug 2026
11,776 shares Rights Restricted Share Units TSXSEDI:4764837 ● 4 - Director of Issuer · Executives · 5 Aug 2026
Rights Restricted Share Units TSXSEDI:4764836 ● 4 - Director of Issuer · Executives · 12 Aug 2026
11,776 shares Rights Restricted Share Units TSXSEDI:4764835 ● 4 - Director of Issuer · Executives · 5 Aug 2026
Rights Restricted Share Units TSXSEDI:4764834 ● 4 - Director of Issuer · Executives · 12 Aug 2026
11,776 shares Rights Restricted Share Units TSXSEDI:4764833 ● 4 - Director of Issuer · Executives · 5 Aug 2026
Rights Restricted Share Units TSXSEDI:4764832 ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
970 shares @ CA$16.85 0.0002% mcap 1.2% of flow Common Shares TSXSEDI:4763628 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
500 shares @ CA$16.84 0.0001% mcap 0.6% of flow Common Shares TSXSEDI:4763627 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
121 shares @ CA$16.835 0.0000% mcap 0.1% of flow Common Shares TSXSEDI:4763626 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
1,343 shares @ CA$16.83 0.0003% mcap 1.6% of flow Common Shares TSXSEDI:4763625 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
4,439 shares @ CA$16.82 0.0009% mcap 5.3% of flow Common Shares TSXSEDI:4763623 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
7,539 shares @ CA$16.81 0.0015% mcap 9.0% of flow Common Shares TSXSEDI:4763622 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
4,607 shares @ CA$16.80 0.0009% mcap 5.5% of flow Common Shares TSXSEDI:4763620 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
2,209 shares @ CA$16.79 0.0004% mcap 2.6% of flow Common Shares TSXSEDI:4763619 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
700 shares @ CA$16.785 0.0001% mcap 0.8% of flow Common Shares TSXSEDI:4763618 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
2,344 shares @ CA$16.78 0.0005% mcap 2.8% of flow Common Shares TSXSEDI:4763616 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
3,000 shares @ CA$16.775 0.0006% mcap 3.6% of flow Common Shares TSXSEDI:4763615 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
200 shares @ CA$16.772 0.0000% mcap 0.2% of flow Common Shares TSXSEDI:4763614 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
11,101 shares @ CA$16.77 0.0022% mcap 13.2% of flow Common Shares TSXSEDI:4763612 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
1,500 shares @ CA$16.765 0.0003% mcap 1.8% of flow Common Shares TSXSEDI:4763611 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
6,520 shares @ CA$16.76 0.0013% mcap 7.7% of flow Common Shares TSXSEDI:4763610 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
4,766 shares @ CA$16.75 0.0010% mcap 5.7% of flow Common Shares TSXSEDI:4763609 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
541 shares @ CA$16.74 0.0001% mcap 0.6% of flow Common Shares TSXSEDI:4763608 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
500 shares @ CA$16.73 0.0001% mcap 0.6% of flow Common Shares TSXSEDI:4763606 Canonical exit: 8 Nov 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 10 Aug 2026
700 shares @ CA$16.785 0.0001% mcap 2.2% of flow Common Shares TSXSEDI:4763594 Canonical exit: 8 Nov 2026 (T+90) 25 of 49 declarations
Load more (24 remaining) 关于 Bausch + Lomb Corporation Bausch + Lomb Corporation 是一家专注于眼健康产品的公司,包括隐形眼镜和眼科药物。该公司在多伦多证券交易所上市,股票代码为 XTSE。